Next Article in Journal
Multimodal Non-Invasive Skin Imaging in Dermatology: Current Modalities, Clinical Applications, and Future Integration
Previous Article in Journal
A Machine Learning Framework for Preeclampsia Prediction at Isidro Ayora Hospital, Ecuador
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Endoscopic Closure After Colorectal ESD: A Literature Review and Meta-Analysis on Its Efficacy in Preventing Adverse Events

1
Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan
2
Department of Gastroenterology, Kyoto Hakuaikai Hospital, Kyoto 603-8465, Japan
3
Department of Gastroenterology, Barwon Health, Victoria 3220, Australia
4
Gastroenterology Unit, Faculty of Medicine, Universiti Teknologi MARA, Bandar Puncak Alam 42300, Malaysia
5
Hepatology and Gastroenterology Unit, Internal Medicine Department, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt
*
Author to whom correspondence should be addressed.
Diagnostics 2026, 16(14), 2148; https://doi.org/10.3390/diagnostics16142148
Submission received: 6 May 2026 / Revised: 14 June 2026 / Accepted: 15 June 2026 / Published: 8 July 2026
(This article belongs to the Special Issue Clinical Advances in Gastrointestinal Endoscopy)

Abstract

Endoscopic closure of mucosal defects after colorectal endoscopic submucosal dissection (ESD) has been increasingly adopted to prevent adverse events. Various devices and techniques, including conventional clips, clips with various technical tips, clip with line, clip with device, special clips, and suturing devices, have been developed, achieving high rates of complete closure (approximately 95% on average), although procedure times and technical complexity vary considerably. Among 14 eligible comparative studies, including randomized controlled trials and retrospective studies published up to April 2026, a meta-analysis was performed to evaluate the efficacy of complete closure after colorectal ESD in preventing delayed bleeding (DB), delayed perforation (DP), and post-ESD coagulation syndrome (PECS). For DB, pooled analysis demonstrated that complete endoscopic closure was significantly associated with a reduced risk of DB (odds ratio [OR]: 0.77, 95% confidence interval [CI]: 0.60–0.97, p = 0.030, I2 = 53.6%). In contrast, no significant differences were observed between the closure and non-closure groups for DP (OR: 0.60, 95% CI: 0.23–1.55, p = 0.290, I2 = 0.0%) or PECS (OR: 0.94, 95% CI: 0.65–1.38, p = 0.765, I2 = 56.6%). In a literature review, reported risk factors for DB include lesion size >50 mm, an ASA score of III or IV, antithrombotic therapy, age ≥75 years, and rectal location. Severe fibrosis and prolonged ESD procedure time have been reported as risk factors for DP, whereas female sex, age ≥70 years, right-sided colon, and lesion size >24 mm have been associated with PECS. Overall, various closure devices and techniques achieve high technical success rates after colorectal ESD. Complete closure appears beneficial for reducing DB, particularly in high-risk patients, whereas its efficacy for preventing DP and PECS remains uncertain. Further studies are warranted.

1. Introduction

Endoscopic submucosal dissection (ESD) enables a high rate of en bloc resection, thereby reducing local recurrence and allowing precise pathological assessment [1,2,3,4]. Although ESD is well established as a standard treatment for colorectal neoplasms, complications such as perioperative bleeding (PB), delayed bleeding (DB), perioperative perforation (PP), delayed perforation (DP), and post-ESD coagulation syndrome (PECS) remain important clinical concerns [2,3,4]. To mitigate the risk of these adverse events, various endoscopic closure after colorectal ESD has been increasingly adopted, with the choice of technique depending on patient risk factors and operator preference [5,6,7,8].

2. Adverse Events After ESD

The rates of PB, DB, DP, and PECS vary widely across studies, largely due to differences in definitions, ESD devices and strategies, geographic regions (Asia vs. Western countries), endoscopist’s skill, lesion location and size, and patient-related factors including anticoagulant use [2,3,4,5,6,7,8]. Definitions of adverse events actually differ among studies. In a representative Japanese study, PB was defined as severe bleeding requiring hemostatic forceps, whereas DB was defined as bleeding requiring endoscopic hemostasis or a ≥2 g/dL decrease in hemoglobin within 30 days after ESD [9]. While some studies have adopted this definition, others have defined DB solely as bleeding requiring endoscopic hemostasis [10]. PP has been defined as a complete defect in the muscular layer during the ESD procedure; however, its diagnosis is partly dependent on the operator’s subjective assessment. In contrast, DP is defined as no obvious perforation during the ESD procedure and no symptoms or free air on X-ray images immediately after ESD, but a subsequent sudden onset of abdominal pain and symptoms of peritoneal irritation accompanied by free air visible on X-ray or computed tomography [7,11]. PECS has been defined as localized abdominal pain (spontaneous pain and tenderness) accompanied by fever elevation (≥37.6 to 38.0 °C) or an inflammatory response (leukocytosis [≥10,000 or >12,000 cells/μL] or elevated C-reactive protein [≥0.5 mg or >3.0/dL]) without radiologic evidence of perforation, occurring more than 6 h after ESD [4,12].
In a large-scale systematic review including 104 studies and 13,833 colorectal ESD procedures, the rates of PB and DB were reported to be 0.39% (95% confidence interval (CI): 0.11–1.3%) and 1.8% (95% CI: 1.4–2.4%) in Asian countries, and 3.3% (95% CI: 1.4–7.6%) and 3.9% (95% CI: 2.5–5.8%) in European and North American countries, respectively [13]. In the same review, those of PP and DP were 3.8% (95% CI: 3.1–4.6%) and 0.18% (95% CI: 0.08–0.42%) in Asia, and 6.6% (95% CI: 4.6–9.4%) and 1.2% (95% CI: 0.29–4.6%) in Western countries, respectively [13]. A recent meta-analysis of 33 studies including 3958 colorectal ESD procedures in Western countries showed that the rates of DB and PP were 3.4% and 5.5%, respectively [14]. Regarding PECS, a systematic review including 19 studies (three prospective, two randomized controlled trials (RCT), and 14 retrospective studies) with 8151 patients who underwent colorectal ESD reported a pooled incidence of 8.9% [15]. Additionally, regarding differences in ESD techniques, a systematic review of eight RCTs comparing underwater ESD with conventional ESD reported DB rates of 3.1% and 2.5% (odds ratio [OR]: 1.34, 95% CI: 0.65–2.74, p = 0.43), PP rates of 4.1% and 4.6% (OR: 1.13, 95% CI: 0.64–2.00, p = 0.68), and PECS rates of 4.4% and 10.4% (OR: 0.38, 95% CI: 0.10–1.43, p = 0.15), respectively [16].

3. Various Closure Devices and Methods

Various closure devices have been developed to prevent complications after colorectal ESD (Table 1). Endoscopic clips include both reopenable and non-reopenable types. In Japan, two non-reopenable clips, EZ Clip (Olympus, Tokyo, Japan) and Zeo Clip (Zeon Medical, Tokyo, Japan), can be reloaded onto a reusable deployment device, making them cost-effective (Figure 1a). Among regular-shaped reopenable clips, there are various sizes, shapes, and costs. SureClip (Micro-Tech, Nanjing, China) has a hole in its arm (8 mm clip and 16 mm clip), which facilitates use in clip-and-line techniques [6]. In contrast, the same company offers a lower-cost clip with a rotation function but without a hole in the arm, SureClip Eco (Micro-Tech, Nanjing, China) (Figure 1c). Its cost is approximately one-third that of the original SureClip. The largest opening width among reopenable clips is 20 mm, achieved by LOCKADO (Micro-Tech, Nanjing, China), and it has 10 teeth for secure closure (Figure 1d). Some clips, including SureClip (Micro-Tech, Nanjing, China), may fail to deploy properly if excessive pressure is applied to the defect base. Therefore, they should be applied gently under low insufflation. In contrast, clips such as Resolution and Resolution 360 (Boston Scientific, Marlborough, MA, USA) and StellaClip (Pentax, Tokyo, Japan) can be deployed regardless of the degree of pressure applied to the defect base (Figure 1e). Among special-shaped clips, Mantis Closure Device (MCD: Boston Scientific, Marlborough, MA, USA) has more sharply angled claws than regular clips, which help prevent slippage (Figure 1f). This clip is designed to grasp the mucosa firmly and enable closure of large defects. Another unique clip with two independently controlled arms is the Dual Action Tissue Closure Device (DAT, Micro-Tech, Nanjing, China) (Figure 1g). It is designed to facilitate closure of large defects, including full-thickness defects after endoscopic full-thickness resection (EFTR). The over-the-scope clip (OTSC: Ovesco Endoscopy AG, Tübingen, Germany) is used for closing deep defects such as muscle injury and perforation and can also be applied after EFTR (Figure 1h) [17]. However, it requires reinsertion after a dedicated device is mounted on the tip of the endoscope. Regarding suturing devices such as OverStitch (Boston Scientific, Marlborough, MA, USA), these systems use sutures and have a more complex structure than clips. Consequently, the procedure time is generally longer than that of clip-based methods. However, they provide durable closure and are typically used for muscle injury and EFTR. Other devices originally designed for different purposes have also been applied to defect closure, such as SureClip Traction Band (SCTB: Micro-Tech, Nanjing, China) as a traction device and Pneumo-Activate EVL Device as a ligation device for esophageal and gastric varices (Figure 1j) [18,19].

4. Efficacy of Various Closure Methods Using Various Devices

A literature search of PubMed up to April 2026 was performed using the key terms (“closure” “suture” OR “Clip”) AND (“endoscopic submucosal dissection” OR “ESD”) AND (“Colorectum” “Colon” OR “Colorectal”) to examine the efficacy of various closure methods in this review. Both single-arm studies and comparative studies on the efficacy of endoscopic prophylactic closure involving ≥5 cases were extracted. When a technique initially reported in fewer than 10 cases was later published in a study including more than 10 cases, the later report was included. The former one remained as appropriate. However, studies whose techniques and devices overlapped were excluded. Studies in which we could not extract the data of the colorectum from the overall data of several organs were also excluded. The clinical outcomes were measured as the rates of DB, DP, and PECS. Defect size, lesion size (when defect size was not available), complete closure rate, and closure time were also examined. According to these criteria, we reviewed 22 clinical studies evaluating various closure methods for colorectal ESD defects (Table 2) [20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41]. We classified reports about closure techniques into five types as follows: 1. Clip+TIPS, 2. Clip+Line, 3. Clip+Device, 4. Special Clip, and 5. Suturing device. Clip+TIPS is the type that does not need any special devices but needs some tips, such as incision, underwater situations, and muscle layer clipping. A representative report is the modified double-layer method (Origami method) [34]. Clip+Line is a clipping method with line, and a representative report is the reopenable clip-and-line method (ROLM) [37]. Clip+Device is a clipping method with a marketed accessory for other uses, and a representative report is clipping with SCTB (Micro-Tech, Nanjing, China) [41]. A special clip and suturing device are marketed for closure. Representatives are MCD and OverStitch, respectively [21,38]. Among 22 reports, the complete closure rate ranged from 73.0% to 100.0%, with an overall mean of 94.9%. Closure time ranged from 6.9 to 56.0 min, with a mean of 15.6 min. Most reports showed no incidence of DB or DP. Nine studies reported the incidence of PECS, which ranged from 0.0% to 9.8% (mean 3.1%). Although simple clip-only methods are convenient, they are often insufficient for complete closure of large defects. This limitation has led to the development of alternative techniques (Clips+TIPS), such as the mucosal incision method, hold-and-drag method, underwater clip closure, mucosa–submucosa clip closure, and the Origami method [20,22,26,27,34]. Clip-and-line techniques (Clip+Line), including ROLM, provide tight and reliable closure without creating dead space; however, they require additional time and technical expertise [25,30,31,36,37]. The use of various devices for closure, including both commercially available and handmade devices, was reported in the Clip+Device category. Among the special clips, the MCD achieved a median closure time of 6.9 min, which was the shortest among the 22 studies reviewed [38]. In the suturing devices category, these devices demonstrated moderate closure times (10.0–13.4 min), with the exception of SutuArt.

5. Case Presentations

Several representative methods are introduced. The Easy and Eco clip-over-the-line method (EOLM) is a modified version of the ROLM [42]. In ROLM, a specific reopenable clip with a hole in its arm, SureClip (8mm and 16 mm, Micro-Tech, Nanjing, China), is used in combination with a line. In contrast, EOLM allows the use of various types of clips. In a representative case, a 30 mm rectal lesion in the lower rectum (high-grade dysplasia) was resected, and SureClip Eco (Micro-Tech, Nanjing, China) with a line, which don’t have a holw in its arm, was used for closure (Figure 2a,b). A clip was first deployed on the distal side of the ulcer margin, and the next clip was inserted along the thread and placed at the proximal side of the mucosal defect (Figure 2c). The line was then pulled to approximate the proximal and distal edges of the defect, and additional clips were sequentially deployed (Figure 2d). By gradually tightening the line, the defect was progressively closed (Figure 2e). Finally, the external end of the line was firmly pulled to achieve complete closure, and the line was cut using either an ESD knife or scissor-type forceps (Figure 2f).
The MCD is a reopenable clip with sharp claws and a width of 11 mm (Figure 1f). In a representative case, a 35 mm lesion in the sigmoid colon was resected by ESD (Figure 3a). After ESD, the surrounding normal mucosa on the anal side of the defect was grasped using MCD (Figure 3b). The device was then rotated 90 degrees by both the operator and assistant (Figure 3c) [43]. Subsequently, the anal-side mucosa was pushed toward the oral-side mucosa, similar to previously described techniques using conventional clips. The MCD was reopened and deployed while maintaining its grip on the anal-side mucosa (Figure 3d), thereby approximating the mucosal edges (Figure 3e). Additional SureClips (width: 16 mm, Micro-Tech, Nanjing, China) were then deployed to achieve complete closure, with a total closure time of 6 min (Figure 3f).
SutuArt is a unique suturing device that uses a surgical needle and suture (Figure 1i). In a representative case, ESD was performed for a 40 mm T1b cancer in the lower rectum, with resection extending into the muscular layer to achieve histopathological complete resection (Figure 4a). A therapeutic single-channel colonoscope and a V-Loc 180 absorbable barbed suture (VLOCL0604; Covidien, Mansfield, MA, USA) were used. The tail of the suture was manually knotted. The suture was delivered to the rectum with the needle secured within a large distal cap to protect the needle tip. After an initial anchoring stitch was placed, a second stitch was placed on the oral side of the defect (Figure 4b). The needle was released from SutuArt and subsequently re-grasped (Figure 4c,d). The mucosal edges were then sutured in a zigzag fashion at 5–10 mm intervals under endoscopic visualization, enabling approximation of the defect edges (Figure 4e). Finally, complete closure was achieved, and the remaining suture and needle were cut using scissor-type forceps (Figure 4f).
The SCTB (Micro-Tech, Nanjing, China) is a traction device consisting of two interconnected elastic silicone bands pre-mounted on a standard 11 mm hemostatic clip (Figure 1i). In a representative case, ESD was performed for a 35 mm cecal lesion (Figure 5a). The SCTB was first deployed on the normal mucosa at the anal side of the defect (Figure 5b). The silicone band was then grasped using SureClip Eco (Micro-Tech, Nanjing, China), preferably at the tip of the second band (Figure 5c). The clip was advanced toward the oral side while maintaining traction (Figure 5d) and deployed on the normal mucosa at the oral side of the defect (Figure 5e). Additional reopenable clips were subsequently deployed to achieve complete closure (Figure 5f).
These representative techniques highlight the versatility of available closure strategies tailored to defect size, location, and procedural complexity.

6. Efficacy of Complete Closure for DB, DP, and PECS According to Reported Studies Including Randomized Controlled Trials and Retrospective Studies: A Meta-Analysis

6.1. Methods

We searched PubMed, Embase, and the Cochrane Library for eligible studies published up to April 2026 to perform a meta-analysis evaluating the efficacy of endoscopic closure after colorectal ESD. The search terms included (“closure” OR “suture” OR “clip”) AND (“endoscopic submucosal dissection” OR “ESD”) AND (“colorectum” OR “colon” OR “colorectal”). The efficacy of endoscopic closure in DB, DP, and PECS was evaluated.
The number of adverse events and total patients in the closure and non-closure groups was extracted from each eligible study. Definitions of complete closure and adverse events were accepted as reported in the original studies.
The inclusion criteria were as follows: (i) patients undergoing colorectal ESD; (ii) prophylactic endoscopic closure after ESD; (iii) the presence of a non-closure control group; (iv) reported incidence of DB, DP, or PECS; (v) RCTs or observational studies (prospective or retrospective cohort studies and case–control studies); and (vi) publication in English.
Two investigators (N.Y. and Y.T.) independently extracted the data and assessed study quality. Any discrepancies were resolved through discussion.

6.2. Statistical Analysis

Odds ratios (ORs) with 95% CIs were calculated for each outcome. When a study contained a zero-event cell, a continuity correction of 0.5 was applied. Studies with no events in either group were excluded from pooled effect estimation for the corresponding outcome.
Pooled analyses were performed using a random-effects model according to the DerSimonian–Laird method because clinical and methodological heterogeneity among studies was anticipated. Statistical heterogeneity was assessed using Cochran’s Q test and the I2 statistic, with an I2 value >50% considered indicative of substantial heterogeneity.
Forest plots were generated for DB, DP, and PECS, including study weights, pooled estimates, and 95% CIs. Because definitions of adverse events varied slightly among the included studies, the original definitions used in each study were accepted. Statistical analyses and forest plots were generated using Review Manager (RevMan) version 5.4 and Python version 3.10.

6.3. Results

A total of 520 studies were identified through the database search. After screening and eligibility assessment, 14 studies were included in the meta-analysis (Table 3) [25,41,44,45,46,47,48,49,50,51,52,53,54,55].
The meta-analysis evaluated the incidence of DB, DP, and PECS in patients undergoing colorectal ESD by comparing closure and non-closure groups. Among the 14 included studies, four were RCTs and 10 were retrospective observational studies. The methodological quality of the four RCTs was assessed using the Cochrane Risk of Bias 2 tool (Supplementary Table S1) [56]. Additionally, those of the 18 observational studies were assessed according to the Newcastle–Ottawa Scale (Supplementary Table S2) [57].
Regarding the meta-analysis, for DB, pooled analysis demonstrated that endoscopic complete closure was significantly associated with a reduced risk of DB (OR: 0.77, 95% CI: 0.60–0.97, p = 0.030, I2 = 53.6%) (Figure 6). For DP, there was no significant difference between the closure and non-closure groups (OR: 0.60, 95% CI: 0.23–1.55, p = 0.290, I2 = 0.0%) (Figure 7). For PECS, endoscopic closure was not significantly associated with risk reduction (OR: 0.94, 95% CI: 0.65–1.38, p = 0.765, I2 = 56.6%) (Figure 8).
Among these 14 studies, the overall rates of DB, DP, and PECS were 4.3% vs. 6.6% (p < 0.001), 0.6% vs. 1.6% (p = 0.109), and 7.5% vs. 8.5% (p = 0.421) in the closure and non-closure groups (Table 4). In the four RCTs, closure significantly reduced DB (0.9% vs. 4.9%, p = 0.004), whereas no significant differences were observed for DP (1.2% vs. 2.0%, p = 0.582) or PECS (15.5% vs. 15.2%, p = 0.913). In the 10 retrospective studies, closure was also associated with a lower rate of DB (4.7% vs. 6.8%, p < 0.001) and a reduced rate of PECS (2.5% vs. 5.3%, p = 0.024), while DP remained similar between groups (0.0% vs. 1.2%, p = 0.085).
Among the four RCTs, lesion size was generally comparable between groups. Osada et al. reported no DB or DP in either group (Table 3) [44]. Lee et al. demonstrated low rates of DB, with no significant difference between the closure and non-closure groups (0.9% vs. 1.8%, p = 1.000), and no significant differences were observed for DP (0.9% vs. 3.6%, p = 0.365) or PECS (8.2% vs. 10.9%, p = 0.491) [45]. Similarly, Nomura et al. reported no significant differences in DB (1.4% vs. 3.6%, p = 0.735), DP (4.2% vs. 3.6%, p = 0.835), or PECS (19.7% vs. 11.9%, p = 0.180) [46]. In contrast, Miyakawa et al. demonstrated a significantly lower rate of DB in the closure group compared with the non-closure group (0.7% vs. 8.5%, p = 0.001), while no differences were observed for DP (0% vs. 0%, p = 1.000) or PECS (19.0% vs. 19.1%, p = 1.000) [47]. Overall, earlier RCTs did not demonstrate a clear benefit of closure, whereas a more recent trial suggested a reduction in DB.
In the 10 retrospective studies, closure was more frequently associated with lower rates of DB (Table 3) [25,41,48,49,50,51,52,53,54,55]. Ogiyama et al. reported a significantly lower DB rate in the closure group compared with the non-closure group (0.0% vs. 8.9%, p = 0.012), and Yamamoto et al. also showed a significant reduction (0.8% vs. 6.7%, p = 0.019) [49,50]. Miyakawa et al. reported similar findings (2.2% vs. 5.9%, p = 0.022) [51]. Takada et al. demonstrated significantly lower DB in the closure group among patients receiving antithrombotic therapy, both in those receiving direct oral anticoagulants (5.2% vs. 10.8%, p = 0.048) and warfarin (6.1% vs. 17.1%, p = 0.049) [53]. In contrast, Cristofaro et al. reported no significant difference between groups (7.2% vs. 6.7%, p = 0.66) [55].
DP was rare across studies, with most reporting no events or no significant differences, such as Omori et al. (0.0% vs. 1.6%, p = 0.581) and Nishio et al. (0.0% vs. 0.0%, p = 1.000) [52,54]. Regarding PECS, the results were inconsistent. Yamasaki et al. demonstrated a significantly lower rate in the closure group (0.0% vs. 11.8%, p = 0.035), and Maruo et al. also reported a significant reduction (3.6% vs. 14.0%, p = 0.042) [25,41]. However, other studies did not show significant differences, such as Nishio et al. (2.2% vs. 5.1%, p = 0.335), and Miyakawa et al. reported a non-significant trend toward higher rates in the closure group (2.9% vs. 0.9%, p = 0.115) [51,54].

6.4. Limitations

The present work should be regarded as a meta-analysis and not a formal PRISMA-compliant meta-analysis. Although a structured literature search, study selection, quality assessment, and random-effects pooled analyses were performed, a PRISMA flow diagram and formal publication-bias assessment were not included. Therefore, the findings should be interpreted as those of a literature review with meta-analysis rather than a formal systematic review and meta-analysis. The definitions of DB, DP, and PECS were not completely uniform among the included studies, which may have contributed to heterogeneity. Most included studies were retrospective observational studies, and only a limited number of RCTs were available. Closure techniques and devices differed among studies, including conventional clips, clip-and-line methods, and other closure devices. Regarding DP, its incidence is considerably lower than that of DB and PECS; therefore, a larger number of cases may be required to clarify whether complete closure reduces its occurrence.

7. Risk Factors of DB, DP, and PECS

DB after colorectal ESD has been associated with several patient- and procedure-related factors. Ogasawara et al. identified continued antithrombotic therapy as an independent risk factor for DB (OR: 3.67, 95% CI: 1.22–11.02, p = 0.021) [58]. In addition, tumor size ≥30 mm (OR: 2.85, 95% CI: 1.34–6.05, p = 0.006) and rectal location (OR: 2.18, 95% CI: 1.01–4.71, p = 0.047) have been reported as significant predictors [59]. Longer procedure time has also been suggested to increase the risk of DB, although results are not entirely consistent across studies. A study proposed a risk scoring system for DB. The risk factors for DB after colorectal ESD were identified as follows: lesion size >50 mm (OR: 3.63, 95%CI: 2.02–7.14, three points), an ASA score of III or IV (OR: 2.26, 95% CI: 1.32–3.92, two points), use of antithrombotic agents (OR: 1.72, 95% CI: 1.01–2.94, one point), age ≥75 years (OR: 1.60, 95% CI: 0.95–2.70, one point), and rectal location (OR: 1.51, 95% CI: 0.92–2.48, one point) [60]. Based on the cumulative predictive score, the incidence of delayed bleeding was 4.1% in the low-to-medium risk group (0–4 points) and 17.5% in the high-risk group (5–8 points).
DP is really rare, and large-scale studies about its risk factors are limited. However, in our previous multicenter study of 4632 colorectal ESD procedures from 13 institutions, the incidence of DP was 0.39% [61]. Multivariate analysis identified severe fibrosis (OR: 4.61, 95% CI: 1.50–14.20, p = 0.007), longer ESD procedure time (OR: 1.01, 95% CI: 1.00–1.02, p = 0.042), and complete closure (OR: 0.12, 95% CI: 0.01–0.96, p = 0.046) as significant factors associated with DP. Accordingly, complete closure may reduce the risk of DP.
PECS is associated with transmural thermal injury. Arimoto et al. reported that right-sided colon location (OR: 3.23, 95% CI: 1.49–7.01, p = 0.003), tumor size ≥30 mm (OR: 2.18, 95% CI: 1.01–4.71, p = 0.047), and female sex (OR: 1.95, 95% CI: 1.02–3.73, p = 0.043) were independent risk factors [62]. Similarly, Ito et al. identified longer procedure time (OR: 1.02 per minute, 95% CI: 1.01–1.03, p < 0.001) as a significant predictor of PECS [63]. Collectively, these findings indicate that DB, DP, and PECS share common risk factors related to procedural complexity and thermal injury during ESD. In particular, factors such as larger lesion size, prolonged procedure time, and difficult dissection conditions (e.g., fibrosis) appear to play central roles across these adverse events. Our recent study made a five-variable PECS-predictive scoring system (FPSS) for early post-procedure prediction of PECS [64]. Multivariate analysis identified five independent predictors of PECS: right colon (OR: 3.55, p = 0.004), elderly female ≥70 years (OR: 2.52, p = 0.022), body temperature ≥37.6 °C (OR: 16.70, p < 0.001), WBC >8000/µL on day 1 (OR: 13.78, p < 0.001), and lesion size >24 mm (OR: 3.03, p = 0.003). The FPSS (range 0–9) achieved an AUC of 0.881, with high negative predictive value (97.4%). These observations underscore the importance of meticulous technique and targeted preventive strategies, including appropriate energy control and selective mucosal closure, especially in high-risk cases.

8. Indications for Endoscopic Closure Based on Reported Evidence and Clinical Factors

Previous reviews and our meta-analysis demonstrated that complete closure significantly reduces DB after colorectal ESD, providing strong evidence for its use [4,5,6,7,8]. However, the overall incidence of DB remains relatively low, occurring in 4.3% and 6.6% of patients in the closure and non-closure groups, respectively (Table 4). In contrast, certain high-risk factors substantially increase the risk of DB, including lesion size >50 mm (OR: 3.63), ASA class III–IV (OR: 2.26), and antithrombotic therapy (OR: 1.72) [60]. Our previous study also demonstrated the efficacy of complete closure in patients receiving anticoagulants, with DB rates of 5.2% and 10.8% in the closure and non-closure groups, respectively [53]. Therefore, complete closure should be strongly considered in high-risk cases, whereas its indication in low-risk cases may be determined individually.
The choice of closure method should be based on defect size, cost, procedure time, operator expertise, and local availability. Most closure techniques have been evaluated for defects <50 mm (Table 2), where procedural efficiency and cost-effectiveness are important considerations. Our previous study reported a median closure time of 6.9 min for defects measuring 20–57 mm, suggesting that this method may be a practical option for defects <50 mm [43]. In contrast, only a limited number of techniques are suitable for defects >50 mm, including suturing devices, the Origami method, and ROLM.
Durable closure may be particularly important in patients receiving antithrombotic agents because DB tends to occur later in these patients [43]. Recent closure techniques using dedicated devices have achieved prolonged maintenance of defect closure. For example, MCD and the SureClip Traction Band maintained complete closure in all cases two days after ESD [38,41], while ROLM and OTSC have also demonstrated durable closure [65,66].
Although complete closure did not significantly reduce DP, this may be attributable to the low incidence of DP and insufficient statistical power. In clinical practice, we preferentially perform complete closure in lesions at high risk of DP, particularly large right-sided lesions and those requiring extensive coagulation near the muscularis propria. However, both DP and PECS are partly caused by thermal injury to the muscle layer during dissection and hemostasis. Consistent with this mechanism, many studies have not demonstrated a significant reduction in PECS with complete closure (Table 3). Therefore, strategies aimed at minimizing thermal injury, such as lower electrosurgical settings and underwater techniques, may be more effective for preventing DP and PECS [67,68,69]. Further studies are expected to prove it.

9. Conclusions

A wide range of closure devices and techniques is available, achieving high technical success rates in defect closure after colorectal ESD. Individual studies suggest that endoscopic closure is associated with a reduction in DB in many settings, although results from earlier RCTs were inconsistent. Pooled analyses confirm that closure significantly reduces DB in both randomized and retrospective data. Complete closure is recommended for preventing DB according to the patients’ risks. In contrast, the incidence of DP is low and does not appear to be significantly affected by closure. The effect on PECS is also controversial. Thus, further well-designed studies including RCTs are warranted to clarify the role of closure in preventing DP and PECS.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/diagnostics16142148/s1, Table S1: The methodological quality of the 4 RCTs using the Cochrane Risk of Bias 2 tool, Table S2: The methodological quality of 18 retrospective studies according to the Newcastle-Ottawa scale.

Author Contributions

N.Y. designed and organized this study. N.Y., K.I., R.K., K.M., T.K., K.Y., H.K., M.S., M.K., T.Y., N.I., O.D., K.U. and Y.T. enrolled patients and collected detailed data. R.K., K.M., R.A.R. E.G. and H.D. helped with the investigation. R.A.R. and H.D. performed English language editing. T.T. supervised this study. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the the Ethics Committee of Kyoto Prefectural University of Medicine (approval code ERB-C-1600-3, approval date 4 June 2024).

Informed Consent Statement

Informed consent was obtained using an opt-out method through notifications posted on the hospital website and within the endoscopy unit.

Data Availability Statement

The patient data used to support the findings of this study are available from the corresponding author upon request. However, some data is restricted by the institutional review board of the Kyoto Prefectural University of Medicine.

Acknowledgments

We thank all the members of the Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, for their help with this study.

Conflicts of Interest

Yoshida N, Inoue K, Dohi O, and Takagi T received a research grant from Fujifilm Co. The other authors declare no conflicts of interest.

References

  1. Tanaka, S.; Kashida, H.; Saito, Y.; Yahagi, N.; Yamano, H.; Saito, S.; Hisabe, T.; Yao, T.; Watanabe, M.; Yoshida, M.; et al. Japan Gastroenterological Endoscopy Society guidelines for colorectal endoscopic submucosal dissection/endoscopic mucosal resection. Dig. Endosc. 2020, 32, 219–239. [Google Scholar] [CrossRef] [PubMed]
  2. Draganov, P.V.; Wang, A.Y.; Othman, M.O.; Fukami, N. AGA institute clinical practice update: Endoscopic submucosal dissection in the United States. Clin. Gastroenterol. Hepatol. 2019, 17, 16–25.e1. [Google Scholar] [CrossRef] [PubMed]
  3. Pimentel-Nunes, P.; Libânio, D.; Bastiaansen, B.A.J.; Bhandari, P.; Bisschops, R.; Bourke, M.J.; Esposito, G.; Lemmers, A.; Maselli, R.; Messmann, H.; et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline—Update 2022. Endoscopy 2022, 54, 591–622. [Google Scholar] [CrossRef] [PubMed]
  4. ASGE Standards of Practice Committee; Faulx, A.L.; Kothari, S. Adverse events of ESD/EMR. Gastrointest. Endosc. 2023, 97, 873–885. [Google Scholar]
  5. Dong, L.; Zhu, W.; Zhang, X.; Xie, X. Does Prophylactic Closure Improve Outcomes After Colorectal Endoscopic Submucosal Dissection? A Systematic Review and Meta-analysis. Surg. Laparosc. Endosc. Percutaneous Tech. 2024, 34, 94–100. [Google Scholar] [CrossRef] [PubMed]
  6. Nomura, T.; Sugimoto, S.; Temma, T.; Oyamada, J.; Ito, K.; Kamei, A. Suturing techniques with endoscopic clips and special devices after endoscopic resection. Dig. Endosc. 2023, 35, 287–301. [Google Scholar] [CrossRef] [PubMed]
  7. Kobara, H.; Tada, N.; Fujihara, S.; Nishiyama, N.; Masaki, T. Clinical and technical outcomes of endoscopic closure of postendoscopic submucosal dissection defects: Literature review over one decade. Dig. Endosc. 2023, 35, 216–231. [Google Scholar] [CrossRef] [PubMed]
  8. Liu, M.; Zhang, Y.; Wang, Y.; Zhu, H.; Xu, H. Effect of prophylactic closure on adverse events after colorectal endoscopic submucosal dissection: A meta-analysis. J. Gastroenterol. Hepatol. 2020, 35, 1869–1877. [Google Scholar] [CrossRef] [PubMed]
  9. Tajiri, H.; Kitano, S. Complications associated with endoscopic mucosal resection: Definition of bleeding that can be viewed as accidental. Dig. Endosc. 2004, 16, S134–S136. [Google Scholar] [CrossRef]
  10. Kobayashi, N.; Takeuchi, Y.; Ohata, K.; Igarashi, M.; Yamada, M.; Kodashima, S.; Hotta, K.; Harada, K.; Ikematsu, H.; Uraoka, T.; et al. Outcomes of endoscopic submucosal dissection for colorectal neoplasms: Prospective, multicenter, cohort trial. Dig. Endosc. 2022, 34, 1042–1051. [Google Scholar] [CrossRef] [PubMed]
  11. Iwatsubo, T.; Takeuchi, Y.; Yamasaki, Y.; Nakagawa, K.; Arao, M.; Ohmori, M.; Iwagami, H.; Matsuno, K.; Inoue, S.; Nakahira, H.; et al. Differences in Clinical Course of Intraprocedural and Delayed Perforation Caused by Endoscopic Submucosal Dissection for Colorectal Neoplasms: A Retrospective Study. Dig. Dis. 2019, 37, 53–62. [Google Scholar] [CrossRef] [PubMed]
  12. Shichijo, S.; Takeuchi, Y.; Shimodate, Y.; Yamashina, T.; Yamasaki, T.; Hayashi, T.; Hirasawa, K.; Fukunaga, S.; Yamaguchi, S.; Asai, S.; et al. Performance of perioperative antibiotics against post-endoscopic submucosal dissection coagulation syndrome: A multicenter randomized controlled trial. Gastrointest. Endosc. 2022, 95, 349–359. [Google Scholar] [CrossRef] [PubMed]
  13. Akintoye, E.; Kumar, N.; Aihara, H.; Nas, H.; Thompson, C.C. Colorectal endoscopic submucosal dissection: A systematic review and meta-analysis. Endosc. Int. Open 2016, 04, E1030–E1044. [Google Scholar] [CrossRef] [PubMed]
  14. Singh, R.R.; Nanavati, J.; Gopakumar, H.; A Kumta, N. Colorectal endoscopic submucosal dissection in the West: A systematic review and meta-analysis. Endosc. Int. Open 2023, 11, E1082–E1091. [Google Scholar] [CrossRef] [PubMed]
  15. Saeed, A.; McGowin, M.D.; Weiss, S.; Ali, I.A.; Hayat, M.; Igbinedion, S.; Radlinski, M.; Mahmood, S.; Kamal, F. Risk Factors of Post-ESD Electrocoagulation Syndrome for Colorectal Neoplasms: A Systematic Review and Comprehensive Meta-Analysis. Dig. Dis. Sci. 2026. [Google Scholar] [CrossRef] [PubMed]
  16. Singh, S.; Mohan, B.P.; Vinayek, R.; Dutta, S.; Dahiya, D.S.; Inamdar, S.; Kumar, V.C.S.; Aswath, G.; Sharma, N.; Adler, D.G. Underwater versus conventional endoscopic submucosal dissection for colorectal lesions: Systematic review and meta-analysis. Gastrointest. Endosc. 2025, 101, 551–557.e5. [Google Scholar] [CrossRef] [PubMed]
  17. Blasberg, T.; Hochberger, J.; Meiborg, M.; Jung, C.; Weber, M.; Brunk, T.; Leifeld, L.; Hosseini, A.S.A.; Wedi, E. Prophylactic clipping using the over-the scope clip (OTSC) system after complex ESD and EMR of large colon polyps. Surg. Endosc. 2023, 37, 7520–7529. [Google Scholar] [CrossRef] [PubMed]
  18. Kobayashi, R.; Yoshida, N.; Inoue, K. Endoscopic closure using SureClip Traction Band for delayed perforation after colorectal endoscopic submucosal dissection. Dig. Endosc. 2025, 37, 206–208. [Google Scholar] [CrossRef] [PubMed]
  19. Tada, N.; Kobara, H.; Nishiyama, N.; Masaki, T. Endoscopic ligation with O-ring closure for a large artificial defect after rectal endoscopic submucosal dissection. Dig. Liver Dis. 2022, 54, 142–143. [Google Scholar] [CrossRef] [PubMed]
  20. Otake, Y.; Saito, Y.; Sakamoto, T.; Aoki, T.; Nakajima, T.; Toyoshima, N.; Matsuda, T.; Ono, H. New closure technique for large mucosal defects after endoscopic submucosal dissection of colorectal tumors (with video). Gastrointest. Endosc. 2012, 75, 663–667. [Google Scholar] [CrossRef] [PubMed]
  21. Kantsevoy, S.V.; Bitner, M.; Mitrakov, A.A.; Thuluvath, P.J. Endoscopic suturing closure of large mucosal defects after endoscopic submucosal dissection is technically feasible, fast, and eliminates the need for hospitalization (with videos). Gastrointest. Endosc. 2014, 79, 503–507. [Google Scholar] [CrossRef] [PubMed]
  22. Akimoto, T.; Goto, O.; Sasaki, M.; Ochiai, Y.; Maehata, T.; Fujimoto, A.; Nishizawa, T.; Yahagi, N. Hold-and-drag” closure technique using repositionable clips for large mucosal defects after colonic endoscopic submucosal dissection. Endosc. Int. Open 2016, 4, E1068–E1072. [Google Scholar] [CrossRef] [PubMed]
  23. Nishizawa, T.; Ochiai, Y.; Uraoka, T.; Akimoto, T.; Mitsunaga, Y.; Goto, O.; Fujimoto, A.; Maehata, T.; Kanai, T.; Yahagi, N. Endoscopic slip-knot clip suturing method: Prospective pilot study (with video). Gastrointest. Endosc. 2017, 85, 433–437. [Google Scholar] [CrossRef] [PubMed]
  24. Wang, J.; Zhao, L.; Wang, X.; Liu, L.; Wang, M.; Fan, Z. A novel endoloop system for closure of colonic mucosal defects through a single-channel colonoscope. Endoscopy 2017, 49, 803–807. [Google Scholar] [CrossRef] [PubMed]
  25. Yamasaki, Y.; Takeuchi, Y.; Iwatsubo, T.; Kato, M.; Hamada, K.; Tonai, Y.; Matsuura, N.; Kanesaka, T.; Yamashina, T.; Arao, M.; et al. Line-assisted complete closure for a large mucosal defect after colorectal endoscopic submucosal dissection decreased post-electrocoagulation syndrome. Dig. Endosc. 2018, 30, 633–641. [Google Scholar] [CrossRef] [PubMed]
  26. Yamasaki, Y.; Harada, K.; Oka, S.; Takashima, S.; Inokuchi, T.; Sugihara, Y.; Takahara, M.; Hiraoka, S.; Okada, H. Feasibility of underwater clip closure for large mucosal defects after colorectal endoscopic submucosal dissection. Digestion 2019, 99, 327–332. [Google Scholar] [CrossRef] [PubMed]
  27. Nishizawa, T.; Banno, S.; Kinoshita, S.; Mori, H.; Nakazato, Y.; Hirai, Y.; Kubosawa, Y.; Sunata, Y.; Matsushita, M.; Uraoka, T. Feasibility of endoscopic mucosa-submucosa clip closure method (with video). Endosc. Int. Open 2018, 06, E1070–E1074. [Google Scholar] [CrossRef] [PubMed]
  28. Nomura, T.; Matsuzaki, I.; Sugimoto, S.; Oyamda, J.; Kamei, A.; Kobayashi, M. Clip-on-clip closure method for a mucosal defect after colorectal endoscopic submucosal dissection: A prospective feasibility study. Surg. Endosc. 2020, 34, 1412–1416. [Google Scholar] [CrossRef] [PubMed]
  29. Abiko, S.; Yoshida, S.; Yoshikawa, A.; Harada, K.; Kawagishi, N.; Sano, I.; Oda, H.; Miyagishima, T. Feasibility of a new ligation using the double-loop clips technique without an adhesive agent for ulceration after endoscopic submucosal dissection of the colon (with video). Gastrointest. Endosc. 2020, 92, 415–421. [Google Scholar] [CrossRef] [PubMed]
  30. Abe, S.; Saito, Y.; Tanaka, Y.; Ego, M.; Yanagisawa, F.; Kawashima, K.; Takamaru, H.; Sekiguchi, M.; Yamada, M.; Sakamoto, T.; et al. A novel endoscopic hand suturing technique for defect closure after colorectal endoscopic submucosal dissection: A pilot study. Endoscopy 2020, 52, 780–785. [Google Scholar] [CrossRef] [PubMed]
  31. Han, S.; Wani, S.; Edmundowicz, S.A.; Soetikno, R.; Hammad, H. Feasibility of endoscopic suturing to prevent adverse events and hospitalization after endoscopic submucosal dissection. Endosc. Int. Open 2020, 8, E1212–E1217. [Google Scholar] [CrossRef] [PubMed]
  32. Yoshida, A.; Kurumi, H.; Ikebuchi, Y.; Kawaguchi, K.; Yashima, K.; Kamitani, Y.; Yasui, S.; Nakada, Y.; Kanda, T.; Takata, T.; et al. New closure method using loop and open-close clips after endoscopic submucosal dissection of stomach and colon lesions. J. Clin. Med. 2021, 10, 3260. [Google Scholar] [CrossRef] [PubMed]
  33. Chu, J.; Min, M.; Shen, W.; Bi, Q.; Zhang, X.; Zhang, H.; Li, A.; Qi, X.; Zhang, H.; Han, B.; et al. Continuous suture technique increases the complete closure rate of colorectal mucosal defects after endoscopic resection: A single-blind, randomized controlled trial. Surg. Endosc. 2023, 37, 8326–8334. [Google Scholar] [CrossRef] [PubMed]
  34. Masunaga, T.; Kato, M.; Sasaki, M.; Iwata, K.; Miyazaki, K.; Kubosawa, Y.; Mizutani, M.; Takatori, Y.; Matsuura, N.; Nakayama, A.; et al. Modified double-layered suturing for a mucosal defect after colorectal endoscopic submucosal dissection (Origami method) (with video). Gastrointest. Endosc. 2023, 97, 962–969. [Google Scholar] [CrossRef] [PubMed]
  35. Farha, J.; Ramberan, H.; Aihara, H.; Zhang, L.Y.; Mehta, A.; Hage, C.; Schlachterman, A.; Kumar, A.; Shinn, B.; Canakis, A.; et al. A novel through-the-scope helix tack-and-suture device for mucosal defect closure following colorectal endoscopic submucosal dissection: A multicenter study. Endoscopy 2023, 55, 571–577. [Google Scholar] [CrossRef] [PubMed]
  36. Tada, N.; Kobara, H.; Nishiyama, N.; Kozuka, K.; Matsui, T.; Chiyo, T.; Kobayashi, N.; Yachida, T.; Fujihara, S.; Masaki, T. Endoscopic Ligation with O-Ring Closure for Mucosal Defects after Rectal Endoscopic Submucosal Dissection: A Feasibility Study (with Video). Digestion 2023, 104, 212–221. [Google Scholar] [CrossRef] [PubMed]
  37. Nomura, T.; Sugimoto, S.; Temma, T.; Oyamada, J.; Ito, K.; Kamei, A. Reopenable clip-over-the-line method for closing large mucosal defects following colorectal endoscopic submucosal dissection: A feasibility study. Endosc. Int. Open 2023, 11, E697–E702. [Google Scholar] [PubMed]
  38. Yoshida, N.; Hirose, R.; Dohi, O.; Inagaki, Y.; Murakami, T.; Inada, Y.; Morimoto, Y.; Kobayashi, R.; Inoue, K.; Ghoneem, E.; et al. A novel reopenable clip with sharp claw for complete closure of mucosal defects after colorectal endoscopic submucosal dissection. Endoscopy 2025, 57, 354–360. [Google Scholar] [CrossRef] [PubMed]
  39. Tanabe, M.; Inoue, H.; Shimamura, Y.; Toshimori, A.; Navarro, M.J.H.; Fujiyoshi, Y.; Fujiyoshi, M.R.A.; Shiomi, D.; Kishi, Y.; Ushikubo, K.; et al. Loop9 closure technique for mucosal defects after colorectal endoscopic submucosal dissection (with video. Endosc. Int. Open 2024, 12, E947–E954. [Google Scholar] [CrossRef] [PubMed]
  40. Mohammed, A.; Gonzaga, E.R.; Hasan, M.K.; Saeed, A.; Friedland, S.; Bilal, M.; Sharma, N.; Jawaid, S.; Othman, M.; Khalaf, M.A.; et al. Low delayed bleeding and high complete closure rate of mucosal defects with the novel through-the-scope dual-action tissue clip after endoscopic resection of large nonpedunculated colorectal lesions (with video). Gastrointest. Endosc. 2024, 99, 83–90.e1. [Google Scholar] [CrossRef] [PubMed]
  41. Maruo, K.; Yoshida, N.; Kobayashi, R.; Inoue, K.; Yasuda, T.; Iwai, N.; Dohi, O.; Uchiyama, K.; Hirose, R.; Dhillon, H.; et al. Traction Device-Assisted Complete Closure to Prevent Colorectal Post-ESD Coagulation Syndrome. Dig. Dis. Sci. 2026, 1–10. [Google Scholar] [CrossRef] [PubMed]
  42. Makiguchi, M.E.; Saito, Y. The running suture with clip and string technique after colonic endoscopic submucosal dissection. Endoscopy 2024, 56, E350–E351. [Google Scholar] [CrossRef] [PubMed]
  43. Yoshida, N.; Dhillon, H.; Inoue, K.; Kobayashi, R.; Dohi, O.; Takagi, T. MANTIS Closure Device–Based Rotate-Suturing Technique by Both the Operator and Assistant for Colorectal Endoscopic Submucosal Dissection Defects. Clin. Endosc. 2026. [Google Scholar] [CrossRef] [PubMed]
  44. Osada, T.; Sakamoto, N.; Ritsuno, H.; Murakami, T.; Ueyama, H.; Matsumoto, K.; Shibuya, T.; Ogihara, T.; Watanabe, S. Closure with clips to accelerate healing of mucosal defects caused by colorectal endoscopic submucosal dissection. Surg. Endosc. 2016, 30, 4438–4444. [Google Scholar] [CrossRef] [PubMed]
  45. Nomura, S.; Shimura, T.; Katano, T.; Iwai, T.; Mizuno, Y.; Yamada, T.; Ebi, M.; Hirata, Y.; Nishie, H.; Mizushima, T.; et al. A multicenter, single blind randomized controlled trial of endoscopic clipping closure for preventing coagulation syndrome after colorectal endoscopic submucosal dissection. Gastrointest. Endosc. 2020, 91, 859–867.e1. [Google Scholar] [CrossRef] [PubMed]
  46. Lee, S.P.; Sung, I.-K.; Kim, J.H.; Lee, S.-Y.; Park, H.S. Effect of prophylactic endoscopic closure for an artificial ulceration after colorectal endoscopic submucosal dissection: A randomized controlled trial. Scand. J. Gastroenterol. 2019, 54, 1291–1299. [Google Scholar] [CrossRef] [PubMed]
  47. Miyakawa, A.; Tamaru, Y.; Mizumoto, T.; Kanazawa, N.; Uchiyama, S.; Maehara, K.; Sumida, Y.; Nakamura, A.; Itobayashi, E.; Shimura, H.; et al. Prophylactic clip closure after endoscopic submucosal dissection of large flat and sessile colo rectal polyps: A multicentre randomised controlled trial (EPOC trial). Gut 2025, 74, 1814–1820. [Google Scholar] [CrossRef] [PubMed]
  48. Fujihara, S.; Mori, H.; Kobara, H.; Nishiyama, N.; Kobayashi, M.; Rafiq, K.; Masaki, T. The efficacy and safety of prophylactic closure for a large mucosal defect after colorectal endoscopic submucosal dissection. Oncol. Rep. 2013, 30, 85–90. [Google Scholar] [CrossRef] [PubMed]
  49. Ogiyama, H.; Tsutsui, S.; Murayama, Y.; Maeda, S.; Satake, S.; Nasu, A.; Umeda, D.; Miura, Y.; Tominaga, K.; Horiki, M.; et al. Prophylactic clip closure may reduce the risk of delayed bleeding after colorectal endoscopic submucosal dissection. Endosc. Int. Open 2018, 06, E582–E588. [Google Scholar] [CrossRef] [PubMed]
  50. Yamamoto, K.; Shimoda, R.; Ogata, S.; Hara, M.; Ito, Y.; Tominaga, N.; Nakayama, A.; Sakata, Y.; Tsuruoka, N.; Iwakiri, R.; et al. Perforation and postoperative bleeding associated with endoscopic submucosal dissection in colorectal tumors: An analysis of 398 lesions treated in Saga, Japan. Intern. Med. 2018, 57, 2115–2122. [Google Scholar] [CrossRef] [PubMed]
  51. Miyakawa, A.; Kuwai, T.; Sakuma, Y.; Kubota, M.; Nakamura, A.; Itobayashi, E.; Shimura, H.; Suzuki, Y.; Shimura, K. The efficacy of prophylactic clip closure of mucosal defects after colorectal endoscopic submucosal dissection on delayed bleeding. Scand. J. Gastroenterol. 2021, 56, 1236–1242. [Google Scholar] [CrossRef] [PubMed]
  52. Omori, J.; Goto, O.; Habu, T.; Ishikawa, Y.; Kirita, K.; Koizumi, E.; Noda, H.; Higuchi, K.; Onda, T.; Akimoto, T.; et al. Prophylactic clip closure for mucosal defects is associated with reduced adverse events after colorectal endoscopic submucosal dissection: A propensity-score matching analysis. BMC Gastroenterol. 2022, 22, 1–9. [Google Scholar] [CrossRef] [PubMed]
  53. Takada, K.; Yoshida, N.; Hayashi, Y.; Togo, D.; Oka, S.; Fukunaga, S.; Morita, Y.; Hayashi, T.; Kozuka, K.; Tsuji, Y.; et al. Prophylactic clip closure in preventing delayed bleeding after colorectal endoscopic submucosal dissection in patients on anticoagulants: A multicenter retrospective cohort study in Japan. Endoscopy 2025, 57, 631–642. [Google Scholar] [CrossRef] [PubMed]
  54. Nishino, K.; Fujita, H.; Yuge, T.; Hongo, M.; Mori, N.; Shimamoto, K.; Kobayashi, Y.; Toyonaga, T.; Ban, H. Effect of double-layered suturing for mucosal defect closure after colorectal endoscopic submucosal dissection on postoperative adverse events: A propensity score-matched retrospective study in Japan. Clin. Endosc. 2025, 58, 881–889. [Google Scholar] [CrossRef] [PubMed]
  55. De Cristofaro, E.; Jacques, J.; Montori, S.; Wallenhorst, T.; Lepilliez, V.; Degand, T.; Le Baleur, Y.; Leclercq, P.; Berger, A.; Chabrun, E.; et al. Impact of prophylactic clipping on delayed bleeding after colorectal endoscopic submucosal dissection: A multicenter propensity score-matched study. Endoscopy 2026, 58, 262–272. [Google Scholar] [CrossRef] [PubMed]
  56. Sterne, J.A.C.; Savović, J.; Page, M.J.; Elbers, R.G.; Blencowe, N.S.; Boutron, I.; Cates, C.J.; Cheng, H.Y.; Corbett, M.S.; Eldridge, S.M.; et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019, 366, l4898. [Google Scholar] [CrossRef] [PubMed]
  57. Stang, A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur. J. Epidemiol. 2010, 25, 603–605. [Google Scholar] [CrossRef] [PubMed]
  58. Terasaki, M.; Tanaka, S.; Shigita, K.; Asayama, N.; Nishiyama, S.; Hayashi, N.; Nakadoi, K.; Oka, S.; Chayama, K. Risk factors for delayed bleeding after endoscopic submucosal dissection for colorectal neoplasms. Int. J. Color. Dis. 2014, 29, 877–882. [Google Scholar] [CrossRef] [PubMed]
  59. Ogasawara, N.; Yoshimine, T.; Noda, H.; Kondo, Y.; Izawa, S.; Shinmura, T.; Ebi, M.; Funaki, Y.; Sasaki, M.; Kasugai, K. Clinical risk factors for delayed bleeding after endoscopic submucosal dissection for colorectal tumors in Japanese patients. Eur. J. Gastroenterol. Hepatol. 2016, 28, 1407–1414. [Google Scholar] [CrossRef] [PubMed]
  60. German, M.E.; Jacques, J.; Albouys, J.; Pina, S.M.; Boukechiche, S.; Albéniz, E.; Vidal, G.; Legros, R.; Dahan, M.; Lepetit, H.; et al. Risk of delayed bleeding after colorectal endoscopic submucosal dissection: The Limoges Bleeding Score. Endoscopy 2024, 56, 110–118. [Google Scholar] [CrossRef] [PubMed]
  61. Yoshida, N.; Hirose, R.; Inoue, K.; Inagaki, Y.; Inada, Y.; Motoyoshi, T.; Yasuda, R.; Hashimoto, H.; Yoriki, H.; Tsuji, T.; et al. Risk factors, clinical course, and management of delayed perforation after colorectal endoscopic submucosal dissection: A large-scale multicenter study. Dig. Dis. Sci. 2025, 70, 2404–2413. [Google Scholar] [CrossRef] [PubMed]
  62. Arimoto, J.; Higurashi, T.; Kato, S.; Fuyuki, A.; Ohkubo, H.; Nonaka, T.; Yamaguchi, Y.; Ashikari, K.; Chiba, H.; Goto, S.; et al. Risk factors for post-colorectal endoscopic submucosal dissection coagulation syndrome: A multicenter, prospective, observational study. Endosc. Int. Open 2018, 6, E342–E349. [Google Scholar] [CrossRef] [PubMed]
  63. Ito, S.; Hotta, K.; Imai, K.; Yamaguchi, Y.; Kishida, Y.; Takizawa, K.; Kakushima, N.; Tanaka, M.; Kawata, N.; Yoshida, M.; et al. Risk factors of post-endoscopic submucosal dissection electrocoagulation syndrome for colorectal neoplasm. J. Gastroenterol. Hepatol. 2018, 33, 2001–2006. [Google Scholar] [CrossRef] [PubMed]
  64. Ghoneem, E.; Yoshida, N.; Hirose, R.; Kobayashi, R.; Iwai, N.; Inoue, K.; Dohi, O.; Konishi, H.; Itoh, Y.; Inagaki, Y.; et al. A comprehensive analysis of prevalence, risk stratification, and early post-procedure predictive scoring for post-endoscopic submucosal dissection coagulation syndrome. Digestion 2026, 1–22. [Google Scholar] [CrossRef] [PubMed]
  65. Kitahara, G.; Wada, T.; Murotani, K.; Doi, K.; Horii, T.; Betto, T.; Watanabe, A.; Ishido, K.; Ikehara, H.; Kusano, C. Evaluation of Delayed Bleeding Prevention and Sustained Closure Using the Reopenable Clip-Over-the-Line Method for Gastric Endoscopic Submucosal Dissection. DEN Open 2026, 6, e70302. [Google Scholar] [CrossRef] [PubMed]
  66. Armellini, E.; Crinò, S.F.; Orsello, M.; Ballarè, M.; Tari, R.; Saettone, S.; Montino, F.; Occhipinti, P. Novel endoscopic over-the-scope clip system. World J. Gastroenterol. 2015, 21, 13587–13592. [Google Scholar] [CrossRef] [PubMed]
  67. Inoue, K.; Yoshida, N.; Kobayashi, R.; Yasuda, T.; Iwai, N.; Dohi, O.; Uchiyama, K.; Tomita, Y.; Hirose, R.; Dhillon, H.; et al. Efficacy of gel immersion endoscopic submucosal dissection for colorectal lesions. Endosc. Int. Open 2026, 14, a28653568. [Google Scholar] [CrossRef] [PubMed]
  68. Dell’uNto, E.; Rimondi, A.; Kalopitas, G.; Bosch, E.M.; Esposito, G.; Yamamoto, H.; Despott, E.J.; Murino, A. The saline-immersion/irrigation technique (SITE) for colonic endoscopic submucosal dissection (ESD): A comprehensive evaluation of outcomes, efficacy, and safety. Saudi J. Gastroenterol. 2025. [Google Scholar] [CrossRef] [PubMed]
  69. Koyama, Y.; Fukuzawa, M.; Aikawa, H.; Nemoto, D.; Muramatsu, T.; Matsumoto, T.; Uchida, K.; Madarame, A.; Morise, T.; Yamaguchi, H.; et al. Underwater endoscopic submucosal dissection for colorectal tumors decreases the incidence of post-electrocoagulation syndrome. J. Gastroenterol. Hepatol. 2023, 38, 1566–1575. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Various devices for closure of colorectal ESD defects. (a). EZ Clip, 8 mm (Olympus, Tokyo, Japan); (b). SureClip, 16 mm (Micro-Tech, Nanjing, China); (c). SureClip Eco, 11 mm (Micro-Tech, Nanjing, China); (d). Lockado, 20 mm (Micro-Tech, Nanjing, China); (e). Resolution 360, 11 mm (Boston Scientific, Marlborough, MA, USA); (f). Mantis Closure Device, 11 mm (Boston Scientific, Marlborough, MA, USA); (g). Dual Action Tissue Closure Device, 15 mm (Micro-Tech, Nanjing, China); (h). Over-the-Scope Clip (OTSC), 14 mm (Ovesco Endoscopy AG, Tübingen, Germany); (i). SutuArt (Olympus, Tokyo, Japan); and (j). SureClip Traction Band, 11 mm (Micro-Tech, Nanjing, China).
Figure 1. Various devices for closure of colorectal ESD defects. (a). EZ Clip, 8 mm (Olympus, Tokyo, Japan); (b). SureClip, 16 mm (Micro-Tech, Nanjing, China); (c). SureClip Eco, 11 mm (Micro-Tech, Nanjing, China); (d). Lockado, 20 mm (Micro-Tech, Nanjing, China); (e). Resolution 360, 11 mm (Boston Scientific, Marlborough, MA, USA); (f). Mantis Closure Device, 11 mm (Boston Scientific, Marlborough, MA, USA); (g). Dual Action Tissue Closure Device, 15 mm (Micro-Tech, Nanjing, China); (h). Over-the-Scope Clip (OTSC), 14 mm (Ovesco Endoscopy AG, Tübingen, Germany); (i). SutuArt (Olympus, Tokyo, Japan); and (j). SureClip Traction Band, 11 mm (Micro-Tech, Nanjing, China).
Diagnostics 16 02148 g001
Figure 2. A case of complete closure using the Easy and Eco clip-over-the-line method (EOLM). (a) A 30 mm rectal lesion in the lower rectum (high-grade dysplasia); (b) It was resected en bloc using ESD; (c) In closure using SureClip Eco (Micro-Tech, Nanjing, China) with a line, a clip with line was first deployed on the distal side of the ulcer margin; (d) A second clip was inserted along the thread and placed at the proximal end of the mucosal defect; (e) The line was then pulled to approximate both edges with sequential clip deployment; (f) Finally the external end of the line was firmly tightened and cut using either an ESD knife or scissor-type forceps, achieving complete closure within 18 min.
Figure 2. A case of complete closure using the Easy and Eco clip-over-the-line method (EOLM). (a) A 30 mm rectal lesion in the lower rectum (high-grade dysplasia); (b) It was resected en bloc using ESD; (c) In closure using SureClip Eco (Micro-Tech, Nanjing, China) with a line, a clip with line was first deployed on the distal side of the ulcer margin; (d) A second clip was inserted along the thread and placed at the proximal end of the mucosal defect; (e) The line was then pulled to approximate both edges with sequential clip deployment; (f) Finally the external end of the line was firmly tightened and cut using either an ESD knife or scissor-type forceps, achieving complete closure within 18 min.
Diagnostics 16 02148 g002
Figure 3. A case of complete closure using the Mantis Closure Device (MCD). (a) A 35 mm lesion in the sigmoid colon was resected using ESD; (b) The surrounding normal mucosa on the anal side of the defect was grasped using MCD; (c) The device was rotated 90 degrees; (d,e) The anal-side mucosa was pushed toward the oral-side mucosa, and the MCD was reopened and deployed while maintaining its grip to approximate the mucosal edges; (f) Additional deployment of SureClips (width: 16 mm, Micro-Tech, Nanjing, China) was performed to achieve complete closure with a total closure time of 6 min.
Figure 3. A case of complete closure using the Mantis Closure Device (MCD). (a) A 35 mm lesion in the sigmoid colon was resected using ESD; (b) The surrounding normal mucosa on the anal side of the defect was grasped using MCD; (c) The device was rotated 90 degrees; (d,e) The anal-side mucosa was pushed toward the oral-side mucosa, and the MCD was reopened and deployed while maintaining its grip to approximate the mucosal edges; (f) Additional deployment of SureClips (width: 16 mm, Micro-Tech, Nanjing, China) was performed to achieve complete closure with a total closure time of 6 min.
Diagnostics 16 02148 g003
Figure 4. A case of complete closure using SutuArt. (a) A 40 mm T1b cancer in the lower rectum was treated with ESD, in which resection extended into the muscular layer to achieve histopathological complete resection. (b) SutuArt was delivered to the rectum with the needle secured within a large distal cap to conceal the needle tip, and after placement of an initial anchoring suture, a second suture was performed on the oral side of the defect. (c,d) The needle was released and subsequently re-grasped. (e) The mucosal edges were sequentially sutured in a zigzag fashion at 5–10 mm intervals under endoscopic visualization to approximate the defect. (f) Complete closure was achieved within 25 min, after which the remaining suture and needle were cut using scissor-type forceps.
Figure 4. A case of complete closure using SutuArt. (a) A 40 mm T1b cancer in the lower rectum was treated with ESD, in which resection extended into the muscular layer to achieve histopathological complete resection. (b) SutuArt was delivered to the rectum with the needle secured within a large distal cap to conceal the needle tip, and after placement of an initial anchoring suture, a second suture was performed on the oral side of the defect. (c,d) The needle was released and subsequently re-grasped. (e) The mucosal edges were sequentially sutured in a zigzag fashion at 5–10 mm intervals under endoscopic visualization to approximate the defect. (f) Complete closure was achieved within 25 min, after which the remaining suture and needle were cut using scissor-type forceps.
Diagnostics 16 02148 g004
Figure 5. A case of complete closure using SureClip Traction Band (SCTB). (a) A 35 mm cecal lesion was resected using ESD; (b) SCTB was deployed on the normal mucosa at the anal side of the defect; (c) The silicone band was grasped using a reopenable clip (SureClip Eco, Micro-Tech, Nanjing, China), preferably at the tip of the second band; (d) The clip was advanced toward the oral side while maintaining traction; (e) The clip was deployed on the normal mucosa at the oral side of the defect; (f) Additional reopenable clips were deployed to achieve complete closure within 9 min.
Figure 5. A case of complete closure using SureClip Traction Band (SCTB). (a) A 35 mm cecal lesion was resected using ESD; (b) SCTB was deployed on the normal mucosa at the anal side of the defect; (c) The silicone band was grasped using a reopenable clip (SureClip Eco, Micro-Tech, Nanjing, China), preferably at the tip of the second band; (d) The clip was advanced toward the oral side while maintaining traction; (e) The clip was deployed on the normal mucosa at the oral side of the defect; (f) Additional reopenable clips were deployed to achieve complete closure within 9 min.
Diagnostics 16 02148 g005
Figure 6. Forest plot of the included studies evaluating the efficacy of complete closure for DB after colorectal ESD. DB: delayed bleeding, ESD: endoscopic submucosal dissection [25,41,44,45,46,47,48,49,50,51,52,53,54,55].
Figure 6. Forest plot of the included studies evaluating the efficacy of complete closure for DB after colorectal ESD. DB: delayed bleeding, ESD: endoscopic submucosal dissection [25,41,44,45,46,47,48,49,50,51,52,53,54,55].
Diagnostics 16 02148 g006
Figure 7. Forest plot of the included studies evaluating the efficacy of complete closure for DP after colorectal ESD. DP: delayed perforation, ESD: endoscopic submucosal dissection [25,41,44,45,46,47,48,52].
Figure 7. Forest plot of the included studies evaluating the efficacy of complete closure for DP after colorectal ESD. DP: delayed perforation, ESD: endoscopic submucosal dissection [25,41,44,45,46,47,48,52].
Diagnostics 16 02148 g007
Figure 8. Forest plot of the included studies evaluating the efficacy of complete closure for PECS after colorectal ESD. PECS: post-ESD coagulation syndrome, ESD: endoscopic submucosal dissection [25,41,45,46,47,51,54].
Figure 8. Forest plot of the included studies evaluating the efficacy of complete closure for PECS after colorectal ESD. PECS: post-ESD coagulation syndrome, ESD: endoscopic submucosal dissection [25,41,45,46,47,51,54].
Diagnostics 16 02148 g008
Table 1. Various devices for closure after colorectal ESD.
Table 1. Various devices for closure after colorectal ESD.
Type of ClipBrand NameCompanySize (mm)Required Channel Diameter Reinsertion
No-reopenable clip (reloaded)Ez clipOlympus6/8/112.8
Partially reopenable clip (reloaded)Zeo clipZeon Medical112.8
Reopenable clipQuickClip2Olympus92.8
Reopenable clipRetentiaOlympus9/12/162.8
Reopenable clipSure ClipMicro-Tech8/11/162.8
Reopenable clipSure Clip EcoMicro-Tech112.8
Reopenable clipLOCKADOMicro-Tech202.8
Reopenable clipResolutionBoston Scientific112.8
Reopenable clipResolution360Boston Scientific112.8
Reopenable clipStellaClipPentax Medical11/132.8
Reopenable clipHemoclipAnrei9/11/13/162.8
Reopenable clipVedClipVedkang11/13/162.8
Reopenable clipClearEndoClipFINEMEDIX11/12/15/162.8
Reopenable clipMENFISMENFIS Lorea
Reopenable clipAssurance Clip STERIS9/11//13/16/182.8
Reopenable clip with sharp clawMantis Closure DeviceBoston Scientific112.8
Reopenable clip with sharp clawInstinct Plus ClipCook Medical162.8
Special-shaped clipDual Action Tissue Closure DeviceMicro-Tech153.2
Special-shaped clipOTSCOvesco Endoscopy AGMini/11/12/142.8Yes
Special-shaped clipOTS Padlock ClipAponos MedicalMini/11/142.8Yes
SuturingOverStitchBoston Scientific 3.2Yes
SuturingSutuArtOlympus 3.2Yes
Suturing X-tack HelixBoston Scientific 2.8
Reopenable clip with band (Traction device)SureClip Traction BandMicro-Tech133.2
Reopenable clip with band (Traction device)SO clipZeon Medical112.8
Endoscopic O-ring (ligation device for varices) Pneumo-Activate EVL DeviceSumitomo bakelite
Endoloop (ligation device for polypectomy)EndoloopOlympus
ESD: endoscopic submucosal dissection.
Table 2. Clinical reports for various devices for closure after colorectal ESD.
Table 2. Clinical reports for various devices for closure after colorectal ESD.
Name of ClosureTypeAuthorYearNumberDefect Size, Median [Range]Complete Closure RateClosure Time, Median [Range]DB RateDP RatePECS Rate
Regular clip with mucosal incisionClip+TIPSOtake et al. [20]20121026.8: [8.0–50.0] *100.015.0 [8.0–35.0]00N/A
Endoscopic suturing (OverStitch, 1st report)Suturing DeviceKantsevoy et al. [21]2014840.0 [30.0–80.0] *100.010.0 ± 5.8 **00N/A
Hold and dragClip+TIPSAkimoto et al. [22]20161940.2 ± 12.0 **94.710.7 ± 7.2 **00N/A
Endoscopic Slip knot clip suturingClip+LineNishizawa et al. [23]2017735 [15.0–46.0]100.017.7 [12.9—20.7]000
Pre-detached endoloop strategyCiip+DeviceWang et al. [24]20171828.0 [12.0–50.0] *100.013.5 [8.0–20.0]000
Line-assisted closureClip+LineYamasaki et al. [25]20186135.0 [23.0–73.0]95.014.0 [6.0–35.0]002.0
Underwater Clip+TIPSYamasaki, et al. [26]2019 2131.0 [18.0–47.0] *100.011.0 [6.0–21.0]00N/A
Mucosa– submucosa clip closureClip+TIPSNishizawa et al. [27] 2018 2531.2 ± 1.1 **96.09.6 ± 4.4 **00N/A
Clip-on clip closureClip+TIPSNomura et al. [28]20203234.0 [28.0–73.0]97.08.0 [3.5–29.2]00N/A
Double- layer methodClip+TIPSAbiko et al. [29]20202632.0 (20.0–24.0) ***88.520.0 [16.0–34.0]003.8
Endoscopic suturing (SutuArt)Suturing DeviceAbe et al. [30]20201138.0 [25.0–55.0]73.056.0 [30.0–120.0] 90N/A
Endoscopic suturing (OverStitch, 2nd report)Suturing DeviceHan et al. [31] 20201338.7 ± 16.1 **100.013.4 ± 5.9 **00N/A
Loop and Open-Close ClipsClip+DeviceYoshida et al. [32] 2021940.9 ± 8.2 **100.018.7 ± 8.0 **00N/A
Continuous barbed suturing line techniqueClip+LineChu et al. [33] 202331 including EMR34 (28.0–49.0) ***93.513 (11.0–16.0) ***003.2
Modified double-layer method (Origami method)Clip+TIPSMasunaga et al. [34]20234738 [25.0–85.0]9417 [9.0–37.0]004
Endoscopic suturing (X-tack helix)Suturing DeviceFarha et al. [35] 20238230.0 (25.0–40.0) ***92.710.0 (6.3–17.3) ***1.20.0N/A
Endoscopic Ligation with O-Ring ClosureClip+DeviceTada et al. [36] 202330 only rectal ESD29.083.325.5 (20.0–30.0) ***3.30N/A
Reopenable clip-over-the-line methodClip+lineNomura et al. [37]20233045 [35.0–70.0]100.025.0 [14.0–52.0]00N/A
MANTISSpecial ClipYoshida et al. [38]20246132.3 [20.0–57.0] *98.46.9 [3.0–15.0]009.8
Loop 9 Clip+DeviceTanabe et al. [39] 202411830.0 [15.0–74.0] *96.614.0 [11.25–17.0] ***001.7
Dual action tissue closureSpecial ClipMohammed et al. [40] 2024107, including 63 EMR40.0 (30.0–45.0) #96.37.0 (5.0–10.0) ***0.90N/A
Traction device-assisted complete closureClip+DeviceMaruo et al. [41]20265535.5 [20.0–60.0]98.28.6 [4.9–32.8]1.803.6
ESD: endoscopic submucosal dissection, EMR: endoscopic mucosal resection, DB: delayed bleeding, DP: delayed perforation, PECS: post-ESD coagulation syndrome, N/A: not applicable, * lesion size, median [range], ** mean ± SD, *** median (interquartile range: IQR), # lesion size median (IQR).
Table 3. Clinical reports the comparison between the closure group and non-closure for DB, DP, and PECS after colorectal ESD.
Table 3. Clinical reports the comparison between the closure group and non-closure for DB, DP, and PECS after colorectal ESD.
Authors, YearPublished YearCountryStudy DesignResected Lesion Size (mm), Mean ± SD
Closure/Non-closure
Closure MethodCase Number
Closure/Control
DB
Closure vs. Non-Closure, % (n)
DP
Closure vs. Non-Closure, % (n)
PECS
Closure vs. Non-Closure, % (n)
Osada et al. [44] 2016JapanRCT677 ± 306/
790 ± 221
Regular clip13/130.0 (0) vs. 0.0 (0)
p = 1.000
0.0 (0) vs. 0.0 (0)
p = 1.000
N/A
Lee et al. [46]2019KoreaRCT19.7 ± 8.5/
22.9 ± 9.8 *
Regular clip110/1100.9 (1) vs. 1.8 (2)
p = 1.000
0.9 (1) vs. 3.6 (4)
p = 0.365
8.2 (9) vs. 10.9 (12)
p = 0.491
Nomura et al. [45]2020Japan RCT22 (20–28)/
20 (20–30) **
Regular clip71/841.4 (1) vs. 3.6 (3)
p = 0.735
4.2 (3) vs. 3.6 (3)
p = 0.835
19.7 (14) vs. 11.9 (10)
p = 0.180
Miyakawa et al. [47]2025JapanRCT38.9 ± 11.2/
40.0 ± 10.7
Regular clip142/1410.7 (1) vs. 8.5 (12)
p = 0.001
0.0 (0) vs. 0.0 (0)
p = 1.000
19.0 (27) vs. 19.1 (27)
p = 1.000
Fujiwara et al. [48]2013JapanRet32 (16–55)/
35 (18–70) #
Regular clip27/410.0 (0) vs. 4.9 (2)
p = 0.666
0.0 (0) vs. 2.4 (1)
p = 0.832
N/A
Yamasaki et al. [25]2018JapanRet35 (23–75)/
30 (20–70) **
Line and clip51/510.0 (0) vs. 3.9 (2)
p = 0.475
0.0 (0) vs. 0.0 (0)
p = 1.000
0.0 (0) vs. 11.8 (6)
p = 0.035
Ogiyama et al. [49]2018JapanRet23.5 ± 7.0/
22.2 ± 9.0 *
Regular clip95/610.0 (0) vs. 8.9 (5)
p = 0.012
N/AN/A
Yamamoto et al. [50]2018JapanRetN/ARegular clip129/2690.8 (1) vs. 6.7 (18)
p = 0.019
N/AN/A
Miyakawa et al. [51]2021JapanRet25.7 ± 9.6/
31.2 ± 16.4
Regular clip275/3392.2 (6) vs. 5.9 (20)
p = 0.022
N/A2.9 (8) vs. 0.9 (3)
p = 0.115
Omori et al. [52]2022JapanRet40.1 ± 12.1/
47.7 ± 16.1
Regular clip97/1221.0 (1) vs. 6.6 (8)
p = 0.088
0.0 (0) vs. 1.6 (2)
p = 0.581
N/A
Takada et al. [53]2025JapanRetDOAC
25 (20–32)/
25 (20–30) ##
Warfarin
25 (20–32)/
25 (20–33) ##
Various clipping212/212
82/82
5.2 (11) vs. 10.8 (23)
p = 0.048
6.1 (5) vs. 17.1 (14)
p = 0.049
N/AN/A
Nishino et al. [54]2025JapanRet35.4 ± 12.5/
37.0 ± 13.6
Double-layered suturing136/1360.7 (1) vs. 4.4 (6)
p = 0.120
0.0 vs. 0.0
p = 1.0
2.2 (3) vs. 5.1 (7)
p = 0.335
Cristofaro et al. [55]2026ItalyRet1199/1943Various clipping1199/19437.2 (86) vs. 6.7 (130)
p = 0.66
N/AN/A
Maruo et al. [41]2026JapanRet35.5 ± 9.0/
37.5 ± 9.2
Traction device55/1361.8 (1) vs. 1.5 (2)
p = 1.000
0.0 (0) vs. 2.2 (3)
p = 0.558
3.6 (2) vs. 14.0 (19)
p = 0.042
ESD: endoscopic submucosal dissection, SD: standard deviation, N/A: not applicable, DB: delayed bleeding, DP: delayed perforation, PECS: post-ESD coagulation syndrome, RCT: randomized control trial, Ret: retrospective study, * lesion size, ** lesion size, median (interquartile range: IQR), # lesion size, mean (range), ## lesion size, median (IQR), closure vs. partial-+non-closure.
Table 4. Efficacy of complete closure for DB, DP, and PECS according to 14 reports, including RCTs and retrospective studies.
Table 4. Efficacy of complete closure for DB, DP, and PECS according to 14 reports, including RCTs and retrospective studies.
ClosureNon-Closurep Value
Overall (14 studies)
DB4.3
(115/2694)
6.6
(247/3740)
<0.001
DP0.6
(4/702)
1.6
(13/834)
0.109
PECS7.5
(63/840)
8.5
(84/985)
0.421
RCT (4 studies)
DB0.9
(3/336)
4.9
(17/348)
0.004
DP1.2
(4/336)
2.0
(7/348)
0.582
PECS15.5
(50/323)
15.2
(49/323)
0.913
Ret (10 studies)
DB4.7
(112/2358)
6.8
(230/3392)
<0.001
DP0.0
(0/366)
1.2
(6/486)
0.085
PECS2.5
(13/517)
5.3
(35/662)
0.024
ESD: endoscopic submucosal dissection, DB: delayed bleeding, DP: delayed perforation, PECS: post-ESD coagulation syndrome, RCT: randomized control trial, Ret: retrospective study.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Yoshida, N.; Inoue, K.; Kobayashi, R.; Maruo, K.; Kano, T.; Yamauchi, K.; Kitae, H.; Seya, M.; Kajiwara, M.; Yasuda, T.; et al. Endoscopic Closure After Colorectal ESD: A Literature Review and Meta-Analysis on Its Efficacy in Preventing Adverse Events. Diagnostics 2026, 16, 2148. https://doi.org/10.3390/diagnostics16142148

AMA Style

Yoshida N, Inoue K, Kobayashi R, Maruo K, Kano T, Yamauchi K, Kitae H, Seya M, Kajiwara M, Yasuda T, et al. Endoscopic Closure After Colorectal ESD: A Literature Review and Meta-Analysis on Its Efficacy in Preventing Adverse Events. Diagnostics. 2026; 16(14):2148. https://doi.org/10.3390/diagnostics16142148

Chicago/Turabian Style

Yoshida, Naohisa, Ken Inoue, Reo Kobayashi, Kazuya Maruo, Taku Kano, Katsuma Yamauchi, Hiroaki Kitae, Mayuko Seya, Mariko Kajiwara, Takeshi Yasuda, and et al. 2026. "Endoscopic Closure After Colorectal ESD: A Literature Review and Meta-Analysis on Its Efficacy in Preventing Adverse Events" Diagnostics 16, no. 14: 2148. https://doi.org/10.3390/diagnostics16142148

APA Style

Yoshida, N., Inoue, K., Kobayashi, R., Maruo, K., Kano, T., Yamauchi, K., Kitae, H., Seya, M., Kajiwara, M., Yasuda, T., Iwai, N., Dohi, O., Uchiyama, K., Tomita, Y., Dhillon, H., Rani, R. A., Ghoneem, E., & Takagi, T. (2026). Endoscopic Closure After Colorectal ESD: A Literature Review and Meta-Analysis on Its Efficacy in Preventing Adverse Events. Diagnostics, 16(14), 2148. https://doi.org/10.3390/diagnostics16142148

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop